HomeInsightsStock Comparison

Sanofi India Ltd vs Strides Pharma Science Ltd Stock Comparison

Sanofi India Ltd vs Strides Pharma Science Ltd Stock Comparison

Last Updated on: May 25, 2025

Key Highlights

  • The Latest Trading Price of Sanofi India Ltd is ₹ 6263 as of 23 May 15:30.
  • The p/e ratio of Sanofi India Ltd changed from 30.8 to 0 over 7 quarters. This represents a CAGR of -100.00% The p/e ratio of Strides Pharma Science Ltd changed from 79.4 to 0 over 5 quarters. This represents a CAGR of -100.00% .
  • The market cap of Sanofi India Ltd changed from ₹ 18578 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of -100.00% The market cap of Strides Pharma Science Ltd changed from ₹ 2888 crore to ₹ 7192 crore over 5 quarters. This represents a CAGR of 107.44% .
  • The revenue of Sanofi India Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 526.3 crore. This represent the decline of -100% The revenue of Strides Pharma Science Ltd for the Mar '25 is ₹ 1205 crore as compare to the Dec '24 revenue of ₹ 1160 crore. This represent the growth of 3.9%.
  • The ebitda of Sanofi India Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 122 crore. This represent the decline of -100% The ebitda of Strides Pharma Science Ltd for the Mar '25 is ₹ 205.56 crore as compare to the Dec '24 ebitda of ₹ 214.45 crore. This represent the decline of -4.15%.
  • The net profit of Sanofi India Ltd changed from ₹ 190.4 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The net profit of Strides Pharma Science Ltd changed from ₹ -9.36 crore to ₹ 85.62 crore over 8 quarters. This represents a CAGR of NaN% .
  • The dividend payout of Sanofi India Ltd changed from 175.77 % to 0 % over 10 quarters. This represents a CAGR of -100.00% The dividend payout of Strides Pharma Science Ltd changed from 104.26 % to 35.08 % over 5 quarters. This represents a CAGR of -58.16% .

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Sanofi India Ltd

  • Sanofi India Limited, was initially incorporated as 'Aventis Pharma Limited' in May, 1956.
  • The Company changed its name from Aventis Pharma Limited to Sanofi India Limited on May 11, 2012.
  • The Company is amongst the leading multinational companies (MNCs) in the Indian Pharmaceutical Market.
  • The Company is primarily engaged in the business of manufacturing and trading of drugs s and pharmaceuticals.
  • It has its own manufacturing facility at Goa.

About Strides Pharma Science Ltd

  • Strides Pharma Science Limited was originally incorporated under the name 'Strides Arcolab Limited ' on June 28, 1990.
  • In FY 2016, Shasun Pharmaceuticals Limited merged with Strides Arcolab Limited forming a new identity 'Strides Shasun Limited', which became effective from 19 November, 2015 and name of the Company was changed to 'Strides Pharma Science Limited' from 'Strides Shasun Limited' effective on July 18, 2018. Strides Pharma Science is a global pharmaceutical company headquartered in Bengaluru, India.
  • The Company is an integrated manufacturer and exporter of Finished Pharmaceutical Dosage forms for both branded and generic.
  • It manufactures a very wide spectrum of ethical pharmaceutical products, OTC products and nutraceuticals.
  • Their dosage forms range includes tablets, capsules, soft gelatin capsules, parenterals and semisolids.

Sanofi India Ltd News Hub

News

Sanofi India to hold board meeting

Sanofi India will hold a meeting of the Board of Directors of the Company on 14 May 2025. ...

Read more

10 May 2025 10:52

News

Sanofi India MD Rodolfo Hrosz resigns

The board of directors accepted Hrosz's resignation during a meeting held on 9 April and e...

Read more

11 Apr 2025 11:01

News

Sanofi India to convene AGM

Sanofi India announced that the 69th Annual General Meeting(AGM) of the company will be he...

Read more

19 Mar 2025 12:01

News

Board of Sanofi India recommends final dividend

Sanofi India announced that the Board of Directors of the Company at its meeting held on 2...

Read more

28 Feb 2025 09:13

News

Board of Schaeffler India recommends Final Dividend

Schaeffler India announced that the Board of Directors of the Company at its meeting held ...

Read more

27 Feb 2025 17:28

News

Sanofi India to conduct board meeting

Sanofi India will hold a meeting of the Board of Directors of the Company on 27 February 2...

Read more

14 Feb 2025 09:41

Strides Pharma Science Ltd News Hub

News

Board of Strides Pharma Science recommends final dividend

Strides Pharma Science announced that the Board of Directors of the Company at its meeting...

Read more

22 May 2025 18:03

News

Strides Pharma Science to announce Quarterly Result

Strides Pharma Science will hold a meeting of the Board of Directors of the Company on 22 ...

Read more

17 May 2025 11:40

News

Strides Pharma's US arm acquires four drugs to bolster portfolio

The portfolio consists of liquids and immediate release solid orals which are in the thera...

Read more

30 Apr 2025 07:51

News

Strides Pharma Science announces incorporation of step-down subsidiary

Arco Lab, a wholly owned subsidiary of Strides Pharma Science has incorporated a new wholl...

Read more

11 Apr 2025 15:34

News

Strides Pharma Science announces acquisition of Singapore-based Amexel

Strides Pharma Global (SPG), a step-down wholly-owned subsidiary of Strides Pharma Science...

Read more

15 Mar 2025 15:45

News

Strides Pharma Science appoints director

Strides Pharma Science has appointed Mukta Arora (DIN: 07225715) as Independent Director o...

Read more

31 Jan 2025 10:49

SWOT Analysis Of Sanofi India Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Strides Pharma Science Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Sanofi India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Strides Pharma Science Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Sanofi India Ltd and Strides Pharma Science Ltd

Which company has a larger market capitalization, Sanofi India Ltd or Strides Pharma Science Ltd?

Market cap of Sanofi India Ltd is 14,424 Cr while Market cap of Strides Pharma Science Ltd is 6,752 Cr

What are the key factors driving the stock performance of Sanofi India Ltd and Strides Pharma Science Ltd?

The stock performance of Sanofi India Ltd and Strides Pharma Science Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sanofi India Ltd and Strides Pharma Science Ltd?

As of May 25, 2025, the Sanofi India Ltd stock price is INR ₹6263.5. On the other hand, Strides Pharma Science Ltd stock price is INR ₹732.65.

How do dividend payouts of Sanofi India Ltd and Strides Pharma Science Ltd compare?

To compare the dividend payouts of Sanofi India Ltd and Strides Pharma Science Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions